The U.S. Federal Circuit Court of Appeals in Washington, D.C. reinstated a 2017 jury verdict against Teva Pharmaceutical Industries, ordering the company to pay GlaxoSmithKline $235.5 million in a 13-year-old induced patent infringement case.

Biogen filed a lawsuit against a New York life sciences company over alleged patent infringements related to the experimental Alzheimer’s disease treatment aducanumab.

A California jury awarded $752 million to Bristol-Myers Squibb over a patent infringement regarding the technology related to a novel cancer therapy.

A British court ruled in favor of Vectura Group and the company’s partner Sandoz over the packaging of a generic version of an inhaler made by bigger rival GlaxoSmithKline.

Mallinckrodt shares fell 12% after a U.S. Court of Appeals upheld a federal district court’s decision to reject a patent infringement lawsuit against Praxair’s nitric oxide drug product delivery system.

British drugmaker Vectura Group Plc won a patent infringement litigation case against GlaxoSmithKline Plc in the United States and was awarded $89.7 million in damages for the period from August 2016 through December 2018.